Bei Li
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 10
- Endocrinology top 5%
- Vibrio bacteria research studies 3
- Microbiology top 10%
- Parasitology top 10%
-
- Bacteriophages and microbial interactions 4
-
- interferon and immune responses 3
-
- Bacterial biofilms and quorum sensing 3
-
- Pneumonia and Respiratory Infections 3
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
- Journals
- SHILAP Revista de lepidopterología (1 paper)Applied and Environmental Microbiology (2 papers)Infection and Immunity (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Bei Li
30 papers receiving 710 citations
Peers
Comparison fields: 5 of 102
- Molecular Medicine 241
- Endocrinology 143
- Applied Microbiology and Biotechnology 24
- Microbiology 42
- Parasitology 36
Countries citing papers authored by Bei Li
This map shows the geographic impact of Bei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bei Li more than expected).
Fields of papers citing papers by Bei Li
This network shows the impact of papers produced by Bei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bei Li. The network helps show where Bei Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 7 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 2 | |
| 10 | 2021 | 47 | |
| 11 | 2021 | 42 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 11 | |
| 14 | 2020 | 20 | |
| 15 | 2020 | 12 | |
| 16 | 2019 | 37 | |
| 17 | 2017 | 7 | |
| 18 | 2016 | 10 | |
| 19 | 2016 | 7 | |
| 20 | 2016 | 39 |
About Bei Li
Bei Li is a scholar working on Molecular Medicine, Endocrinology and Periodontics, having authored 32 papers that have together received 723 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Bacteriophages and microbial interactions (4 papers), interferon and immune responses (3 papers), Vibrio bacteria research studies (3 papers), Bacterial biofilms and quorum sensing (3 papers), Pneumonia and Respiratory Infections (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Molecular Medicine (241 citations), Endocrinology (143 citations) and Applied Microbiology and Biotechnology (24 citations). Bei Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Dongsheng Zhou, Changting Liu, Zhenhong Chen, H. J. Yang, Qin Ou, Li Xu, Xiao‐Hua Zhang, Xinli Shi, Jiwen Liu and Xiaolei Wang. Their work appears in journals such as SHILAP Revista de lepidopterología, Applied and Environmental Microbiology and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.